Tidal Vision, a Bellingham, WA-based biomolecular technologies company, received an investment from Milliken & Company.
The amount of the deal was not disclosed.
The investment and the strategic partnership will accelerate the introduction of biodegradable chemistries across the markets that Milliken serves and is the latest in a series of investments made as part of Milliken’s ventures program.
Led by CEO Craig Kasberg, Tidal Vision specializes in scalable biomolecular solutions dedicated to addressing critical industrial challenges. Its chitosan-based technologies provide high-performance solutions throughout the water treatment, agriculture, and material science industries.
The company has more than 200 employees and facilities in five states.
FinSMEs
25/11/2024